Tech Company Financing Transactions
PathologyWatch Funding Round
On 5/13/2020, PathologyWatch raised $5 million in Series A investment from Rock Creek Capital, SpringTide Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/13/2020
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Rock Creek Capital (Lead Investor)
SpringTide Ventures (Lead Investor) (Austin Waters)
Proceeds Purpose
PathologyWatch will utilize this series A funding to strengthen outreach to dermatology clinics nationwide.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
166 East 5900 South B104
Salt Lake City, UT 84107
USA
Salt Lake City, UT 84107
USA
Phone
Website
Email Address
Overview
PathologyWatch is working with clinical dermatology practices like yours to manage your pathology workflow using a digital model. This helps to improve the quality of patient care, reduce costs, and open up new potential steams of revenue for clinics and hospitals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Lambert
Chief Medical Officer
Gregory Osmond
VP - Bus. Development
Michael Torno
Browse more venture capital transactions:
Prev: 5/13/2020: SmileSnap venture capital transaction
Next: 5/13/2020: IntelliBoard venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs